Evolent Health, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Evolent Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.5 times its market value (net debt). Lower than 96% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 95% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.3×Over the last 3 years its own operating cash covered its investment spending (capex) 2.3 times.
Higher than 75% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$98Sales grew 39% in 3 years, but profit fell: $98 less profit per $100 of extra sales.
Lower than 87% of Healthcare companies in United States.
Asset Productivity Ratio
+39% / +5%In 3 years sales changed by +39% while total assets changed by +5%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.5×Debt due within a year is covered 2.5 times by its yearly operating cash.
Higher than 75% of Healthcare companies in United States.
Cash Cushion Ratio
1.5× debtDebt, after subtracting cash, is 1.5 times its market value (net debt).
Lower than 96% of Healthcare companies in United States.
Tangible Assets Ratio
33%Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 92% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 95% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Evolent Health, Inc. made a loss over the last year. Evolent Health, Inc. owes $0.81 for every $1 it owns. Evolent Health, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEvolent Health, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.44The share price is 1.44 times Evolent Health, Inc.'s book value per share, lower than 69% of Healthcare companies in United States.
Market cap
$553 MThe total market value of all of Evolent Health, Inc.'s shares at today's price (share price × number of shares), larger than 56% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$383 MWhat Evolent Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.39Net worth divided by the number of shares. The share price of $4.89 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
-67.0%Evolent Health, Inc. lost 67.0% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
Owes vs Owns
0.81×Evolent Health, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.
Dividend yield
NoneEvolent Health, Inc. does not currently pay a dividend.
Revenue growth
-27%Revenue fell 27% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Profit growth
LossEvolent Health, Inc. made a loss in each of the last two years.
Profit margin
-28.5%Evolent Health, Inc. lost $28 for every $100 of revenue.
Interest cover
Not coveredEvolent Health, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtEvolent Health, Inc. had $838 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Evolent Health, Inc.: $553 M ÷ $383 M (30 Jun 2026) = 1.4.
What is Evolent Health, Inc.'s return on equity?
Evolent Health, Inc. lost 67.0% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
How much does Evolent Health, Inc. owe compared with what it owns?
Evolent Health, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.
Does Evolent Health, Inc. pay a dividend?
No. Evolent Health, Inc. does not currently pay a dividend.
Is Evolent Health, Inc.'s revenue growing?
Revenue fell 27% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.